Crosslinked PAG Hydrogel for Tumor Dormancy Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current models fail to effectively recapitulate tumor dormancy and metastatic relapse conditions in vitro, limiting understanding of molecular mechanisms and hindering the development of therapeutic strategies for preventing metastasis.
Innovation Solution
A system using an engineered synthetic material-based platform with a crosslinked poly(alkylene glycol) (PAG)-based hydrogel composition that mimics the extracellular matrix, allowing for control of microenvironmental properties and cell-matrix interactions to direct cancer cells towards specific fates, including dormancy and invasive growth states.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current in vitro models are used to study tumor dormancy, then simplicity and ease of operation are maintained, but the ability to recapitulate tumor dormancy and metastatic relapse conditions is insufficient
Solution Approach 1:
The patent modifies physical-chemical parameters of the hydrogel matrix including crosslinking density, mesh size, and stiffness to recapitulate in vivo tumor microenvironment conditions. By systematically varying these parameters, the model achieves reliable dormancy induction while maintaining in vitro simplicity
Solution Approach 2:
The patent employs composite hydrogel materials combining natural and synthetic polymers to create a matrix that mimics the complex extracellular matrix. This composite approach enables simultaneous control of mechanical properties and biochemical signals necessary for dormancy while keeping the system manageable
2Reliability
If complex in vivo models are used to study metastatic mechanisms, then comprehensive biological relevance is achieved, but difficulty of detecting and measuring single DTCs and tracking fate increases
Solution Approach 1:
The patent extracts the essential features of the tumor microenvironment into a simplified hydrogel system, isolating key parameters such as matrix stiffness and biochemical cues. This extraction maintains biological relevance for dormancy studies while eliminating the complexity of whole-organism tracking
Solution Approach 2:
The patent creates an in vitro copy of the in vivo tumor niche using hydrogels with matched mechanical and biochemical properties. This copying approach preserves the biological signals that induce dormancy while enabling easier observation and measurement compared to in vivo models
3Adaptability or versatility
If traditional cell culture systems are used, then ease of manufacture and operation are maintained, but ability to control microenvironmental properties and cell-matrix interactions is limited
Solution Approach 1:
The patent employs dynamic hydrogel systems where microenvironmental properties such as stiffness and degradation rate can be tuned and adjusted. This dynamic control allows researchers to simulate different tissue environments and temporal changes in the tumor microenvironment while maintaining a relatively simple hydrogel-based platform
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the investigation of mechanisms underlying tumor dormancy and metastatic relapse, facilitating the identification of potential targets and the development of therapeutic strategies to prevent metastasis and prolong dormancy.
Implementation Method 1
crosslinked poly(alkylene glycol) (PAG)-based hydrogel composition
Implementation Method 2
formed by photopolymerizing a polymer-peptide macromer in the presence of a photoinitiator
Data Source
AI summary
The present invention discloses crosslinked poly(alkylene glycol) (PAG)-based hydrogel compositions, systems containing a plurality of cancer cells in contact with a cell culture media and encapsulated in the crosslinked PAG-based hydrogel composition and methods of making such crosslinked hydrogel compositions and systems. Also disclosed herein are methods of using such compositions and systems, such as, for example for screening an agent for effectiveness of the agent against cancer cells. Also disclosed herein are kits containing one or more components including one or more systems of the present disclosure and one or more instructions.